Mirae Asset Global Etfs Holdings Ltd. Rocket Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 198,771 shares of RCKT stock, worth $4.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
198,771Holding current value
$4.14 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$369 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$191 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$129 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$121 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$90.2 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.58B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...